IL18 and Alzheimer disease: Increased IL-18 plasma levels and elevated IL-18 production by stimulated peripheral blood mononuclear cells have been associated with greater clinical severity, and IL-18 has been found to colocalize with Aβ plaques in the AD brain [243–245].